🌎 Deepening Latin American Ties — Kossel Medtech Strikes a New Chord in the Land of Samba

Hospitalar 2025 | São Paulo, Brazil | May 20–23 Hospitalar, one of South America’s most influential healthcare exhibitions, concluded successfully in São Paulo. Leveraging Brazil’s strategic position in Latin America, the event has become a key platform for regional medical integration and international collaboration. At this major event, Kossel Medtech showcased a portfolio of flagship products […]

Kossel Medtech Shines at EuroPCR 2025 | 🇫🇷 Paris, May 20–23

Chinese medical innovation is accelerating its global journey! At EuroPCR 2025, one of the world’s leading cardiovascular events, Kossel Medtech proudly showcased flagship products from our Peripheral Intervention, Coronary Intervention, and Cardiac Electrophysiology lines. We connected with experts and partners from Asia, the Middle East, South America, and Europe, sharing insights and exploring new global […]

The Clinical Research of Mistent® Coronary Drug Eluting Stent System

一、Stent Design The biodegradable coating (PLGA polymer combined with sirolimus crystals) was realized based on supercritical fluid technology, which gave birth to the Mistent® coronary drug-eluting stent. It has two distinctive features: “Quick Healing” and “Long-lasting Drug Efficacy”. The biodegradable polymer enables rapid endothelialization and reduces chronic inflammation and the occurrence of stent thrombosis; the […]

PAIRS 2025 | Expanding Horizons, Connecting Globally

We had a fantastic time at PAIRS 2025, held from April 9–12 at the Dubai World Trade Centre! As a company committed to innovation in vascular intervention, Kossel proudly showcased our flagship products from three key product lines: Peripheral Intervention, Coronary Intervention, and Cardiac Electrophysiology. It was a great opportunity to demonstrate our R&D strength […]

Exciting News | Seledora® Coronary Scoring Balloon Catheter Approved!

On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel’s independently developed Octoparms® II Vena Cava Filter has also been approved by the NMPA today (Registration […]

Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate!

On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary Mixin Medtech was also approved by the National Medical Products Administration (NMPA) today. […]

An Analysis of the “Long-lasting Efficacy” of the MiStent Stent

The MiStent coronary drug-eluting stent, an important overseas transformation project of Kossel Medtech has officially entered the Chinese market with two major advantages of “rapid healing and long-lasting efficacy”, providing a new clinical option for PCI surgeries. This issue will introduce the design story behind the realization of the “long-lasting efficacy” function of the MiStent […]

Mistent® Fast Healing” in Stent Analysis

Mistent® coronary drug-eluting stent system, as an important overseas transformation project of Kossel Medtech, has officially launched in the Chinese market with two advantages of “fast healing and long efficacy”, providing a new clinical choice for PCI surgery. This article brings you the design story behind the realization of the “fast healing” function of Mistent® […]

Literature Express | Expert Consensus on the Prevention and Treatment Management Guidelines for Venous Thromboembolism (VTE) in Zhejiang Provincial Hospitals (Second Edition) Issue 1

Author: Zhejiang Pulmonary Embolism and Deep Vein Thrombosis Prevention and Treatment Alliance Background and Objectives The Expert Consensus on the Prevention and Treatment Management Guidelines for Pulmonary Embolism and Deep Vein Thrombosis in Zhejiang Provincial Hospitals is based on the construction of prevention and treatment management systems in medical institutions at all levels and baseline […]